Related Experiment Videos
A general method for greatly improving the affinity of antibodies by using combinatorial libraries
Arvind Rajpal1, Nurten Beyaz, Lauric Haber
1Bioren Inc., 100 Glenn Way, Suite 1, San Carlos, CA 94070, USA.
Summary
Look-through mutagenesis (LTM) rapidly maps antibody binding sites, enhancing antibody affinity by up to 870-fold. This method significantly improves TNF-alpha neutralization, offering broad applications for protein engineering.
Area of Science:
- Protein engineering
- Antibody engineering
- Immunology
Background:
- Antibody affinity maturation is crucial for therapeutic development.
- Optimizing antibody binding sites requires efficient methods to explore combinatorial mutations.
- Previous optimization of the anti-TNF-alpha antibody D2E7 presented a challenge due to its high initial affinity.
Purpose of the Study:
- To apply and validate the Look-through Mutagenesis (LTM) method for antibody affinity maturation.
- To comprehensively map the energetic landscape of an antibody-binding site.
- To generate novel antibody variants with significantly enhanced affinity and function.
Main Methods:
- Look-through Mutagenesis (LTM) was employed to introduce single amino acid mutations across all complementarity determining regions (CDRs).
- Yeast surface display was used to generate and select antibody libraries.
- Combinatorial beneficial mutagenesis and FACS selection were applied to further enhance affinity.
Main Results:
- 38 beneficial substitutions were identified in 21 CDR positions, increasing TNF-alpha binding affinity.
- Engineered antibody variants demonstrated 500- to 870-fold higher affinities compared to the parent antibody.
- Enhanced affinities correlated with a 15- to 30-fold improvement in TNF-alpha neutralization.
Conclusions:
- LTM is a facile and rapid strategy for comprehensive energetic mapping of antibody-binding sites.
- The LTM approach enables significant affinity maturation of antibodies.
- This methodology holds broad applicability for engineering antibodies and other proteins with improved binding properties.